Marketed as Spiriva with Handihaler in Canada
Marketed as Spiriva with Handihaler in United Kingdom
What is a generic medication?
Generic medications are significantly discounted copies of brand name medication that have the same active ingredients, intended use, dosage, side effects, effects, and route of administration as the original brand name medication. In other words, generic medications have the same pharmacological effects as their brand-name counterparts. Over half of all prescribed medications are for generic medications.
Please Note: The Rotahaler device needed for this product will be supplied with your order.
What is Spiriva?
Spiriva is a medicine prescribed to people suffering from chronic obstructive pulmonary disease (COPD). This umbrella term includes several serious lung conditions such as chronic bronchitis, emphysema, and non-reversible asthma. Patients use Spiriva daily to alleviate breathing problems.
How It Works
The active substance in Spiriva, tiotropium bromide, relaxes muscles in the airwaves, thus increasing airflow to the lungs. Patients inhale the drug through a specially-formulated device. The medication needs to be administered once daily as part of an ongoing maintenance regime.
Spiriva should not be used to treat onset or acute breathing problems. Patients who experience sudden attacks of breathlessness must be prescribed separate medications to deal with this problem.
Spiriva Has Two Easy-to-Use Applications
This is a propellant-free hand-held inhaler. The medicine is stored as a solution in the cartridge of the device. Because of its special design, this inhaler discharges the medicinal mist slowly. Additionally, it is able to create an aerosol with very fine particles.
This translates into higher lung deposition and an ability to achieve high efficiency at a lower dose of medication. The inhaler is also easy to store and carry and features a dose-release button that measures the amount of medicine discharged so one dose is equal to two puffs.
With the Handihaler, medicine is delivered in the form of a dry powder in capsule form. Each capsule contains a single dose of the medicine. To administer the medication, patients must breathe in twice for a full dose. Note that capsules should never be swallowed, and are for oral inhalation use only.
This is a prescription medication and should only be used after consulting a physician. Prior to starting Spiriva, the possibility of allergic reactions and negative side effects need to be discussed with a doctor.
The information above is a quick summary of facts about Spiriva, provided by third parties. Patients should always refer to a physician for medical advice on how to administer this drug, along with any other specific questions they may have.
Generic Alternatives to Spiriva
Patients can buy generic alternatives to Spiriva via our international online pharmacy. Before deciding to switch to an alternative containing tiotropium bromide, patients need to consider the fact that Spiriva is administered via two patented devices which, the manufacturer claims, allow for the active substance reaching a patient’s lungs in a more effective manner, compared to other standard systems.
As with the brand-name drug, patients should avoid taking its generic alternatives if they are allergic to milk proteins. This medicine can interact with a number of others, including antihistamines and atropine, as well as some medications for irritable bowel syndrome, Parkinson’s disease, ulcers and urinary tract issues.
The most common side effects of taking this drug include dry mouth, constipation, stomach pain, vomiting, and indigestion.
Spiriva in the News
FDA expands indication for Boehringer Ingelheim’s Spiriva Respimat
In February 2017, the Food and Drug Administration has approved the use of the Spiriva Respimat for children ages 6 years and older. The asthma medication was previously only allowed for use by adults and adolescents.
New Trial to Study Efficacy of Nebulized Spiriva
US company, Glenmark Pharmaceuticals, has announced receiving FDA approval for a trial investigating the efficacy of its own version of a drug, which targets chronic obstructive pulmonary disease (COPD). A total of 155 patients are participating in the trial.
Cipla’s Gain in German Firm’s Drug Patent Loss
Indian drugmaker, Cipla, will continue selling a generic version of Spiriva after the Indian authorities revoked German firm, Boehringer Ingelheim’s, patent on the drug. Cipla’s generic drug is sold under the brand name Tiova in India.
IMPORTANT DISCLAIMER: All medical content is supplied by a third party company who is independent from this web site. As such, this web site can not guarantee the reliability, accuracy, and /or medical efficacy of the information provided. In all circumstances, you should seek the advice of a health professional pertaining to drug, treatment and/or medical condition advice. Note that not all products are shipped by our contracted Canadian pharmacy. This website contracts with dispensaries around the world that ship products directly to our customers. Some of the jurisdiction include but are not limited to United Kingdom, Europe, Turkey, India, Canada, Vanuatu, Mauritius, and USA. The items within your order may be shipped from any one of these jurisdiction depending on the availability and cost of the products at the time you place your order. The products are sourced from these countries as well as others. Please note that the product appearance may vary from actual product received depending on availability.